Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jul-Aug;58(1):69-75.
doi: 10.1016/j.pcad.2015.04.002. Epub 2015 Apr 30.

The Look AHEAD Trial: Implications for Lifestyle Intervention in Type 2 Diabetes Mellitus

Gareth R Dutton  1 , Cora E Lewis  2
Affiliations
Review

The Look AHEAD Trial: Implications for Lifestyle Intervention in Type 2 Diabetes Mellitus

Gareth R Dutton et al. Prog Cardiovasc Dis. 2015 Jul-Aug.

Abstract

Given the array of adverse health consequences of obesity, including increased risk for type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD), the Look AHEAD trial (N=5145) was conducted to test the hypothesis that an intensive lifestyle intervention (ILI) for weight loss would achieve significantly greater reductions in CVD morbidity and mortality than a control condition of diabetes support and education (DSE) among participants with T2DM. A number of significant and long-term improvements were observed for ILI, including body weight, physical fitness and physical function, glucose control, quality-of-life (QoL), and healthcare costs. However, ILI did not significantly reduce CVD-related morbidity/mortality (i.e., CVD death, non-fatal MI, non-fatal stroke, hospitalized angina) after nearly 10 years of follow-up. There was a suggestion of heterogeneity of response based on the history of prior CVD at baseline (p=0.06). Despite the overall lack of CVD risk reduction, ILI remains important for care of patients with T2DM, particularly when accompanied by medication management. In particular, ILI may be an appealing option for patients wanting to minimize medication intensification. Also, ILI carries with it other potential benefits important to patients (e.g., improvements in physical functioning and QoL). Based on data from other trials, intensive medication management, such as tight glycemic control, is not without potential risks, which should be weighed in making treatment decisions. Future research is needed to determine if results observed in this trial would be replicated among younger patients, those without established T2DM, and/or those with no pre-existing CVD.

Keywords: Cardiovascular disease; Lifestyle intervention; Type 2 diabetes mellitus; Weight loss.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: Dr. Lewis receives research grant support for her role as Principal Investigator (paid to the University of Alabama at Birmingham) from Novo Nordisk

References

    1. Jensen MD, Ryan DH, Apovian CM, et al. AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Obesity Society. J Am Coll Cardiol. 2013;63:2985–3023. - PubMed
    1. Field AE, Barnoya J, Colditz GA. Epidemiology and Health and Economic Consequences of Obesity. In: Wadden TA, Stunkard AJ, editors. Handbook of Obesity Treatment. New York: The Guilford Press; 2002. pp. 3–18.
    1. National Heart Lung Blood Institute . In: Clinical Guidelines on the Identification, Evaluation, and treatment of overweight and bbesity in adults: the evidence report. NHLBI Obesity Education Initiative Expert Panel, editor. NHLBI; 1998.
    1. Coakley EH, Kawachi I, Manson JE, Speizer FE, Willet WC, Colditz GA. Lower levels of physical functioning are associated with higher body weight among middle-aged and older women. Int J Obes Relat Metab Disord. 1998;22(10):958–965. - PubMed
    1. Fine JT, Colditz GA, Coakley EH, et al. A prospective study of weight change and health-related quality of life in women. JAMA. 1999;282(22):2136–2142. - PubMed

Publication types

MeSH terms